In addition, a recent report indicated increased MDSCs [16] and PD-1+ CD4 T cells [48] in cancer patients receiving chemo-radiotherapy, which provides a rationale for combined treatment with chemo-radiotherapy and PD-1 blockade. This evidence concerns the gene CD4 and cancer.